Ethos Technologies Inc (LIFE)
NASDAQFinancialsInsurance - BrokersSnapshot 2026-09-04
$39.85+5.67%
Close 2026-09-04 · 1-day change
NASDAQFinancialsInsurance - BrokersSnapshot 2026-09-04
QuarterlyIQ Insights · LIFE
Price, fair value, and the multiples that frame it on the same time axis. Scroll over the price chart to zoom.
Daily closes. Earnings/event dots inline.
A consensus fair price across 11 valuation methods, at three horizons. As of 2026-09-04. Estimates are diagnostics, not price targets. Short-horizon estimates are close to coin-flips, so confidence is a method-agreement read, not a prediction.
Today's peer multiple on trailing earnings, with no growth credited. This is the headline read.
Adds projected growth, so it leans optimistic by design. Read it as upside context, not a base case.
We take the 12-month fair value above and grade our own number — how the market prices this name versus what we'd justify, and where the two diverge.
At $40 LIFE trades at 29× p/e — 2.3× the 12× p/e peer median, and above its own 23× history. The market is re-rating it beyond its own range; our $23 fair value is low-confidence here. Analysts target $30–$40. Note: our $23 fair value sits below the entire analyst range ($30–$40). Not investment advice.
One valuation read at a 12-month horizon, plus how price compares to peers and the company's own history.
Score 100 = cheapest in the cohort, 0 = richest. Bars are filled left-to-right based on the peer-relative score (or PEG/self-history where shown).
Each method's implied share price per horizon. Provisional rows use a projected (historical-CAGR) growth input rather than analyst or management guidance.
| Method | Horizon | Est. price | Multiple | Per-share input | EPS source | Confidence |
|---|---|---|---|---|---|---|
| analyst target | 12M | $32.50 | — | — | Analyst | high |
| dcf fcfe | 12M | $4.96 | — | — | Analyst | high |
| dcf fcff | 12M | $6.67 | — | — | Analyst | high |
| graham number | 12M | $14.95 | — | — | TTM | high |
| Peer P/B | 12M |
A “consensus-then vs. actual-now” overlay is on the way — what our valuation estimate said on a past date versus where the price actually landed.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
A long-thesis check that carries the widest uncertainty of the three horizons.
$30.00 – $40.00 (median $34.00) · 6 analysts · as of 2026-08-04
Only expensive valuation — not the full expensive x weak x turbulent stack. Regime (Mania) does not concentrate fragility.
For similar setups historically (n=20,154): about 33% saw a 20%+ drawdown, and roughly 76% of those did not recover within the year. These are historical base rates for the cohort, not a forecast of this stock.
Looks more expensive than peers.
Richer than its own typical valuation.
Trailing four: 2025-Q1, 2025-Q2, 2026-Q1, 2026-Q2
| $9.72 |
| 1.3 |
| 7.25 |
| TTM |
| high |
| Peer P/FCF | 12M | $11.91 | 11.1 | 1.08 | TTM | high |
| Peer P/E | 12M | $16.99 | 12.4 | 1.37 | TTM | high |
| Peer P/S | 12M | $24.83 | 2.9 | 8.63 | TTM | high |
| residual income | 12M | $9.99 | — | — | TTM | high |
| Own P/E history | 12M | $31.67 | 23.1 | 1.37 | TTM | high |
| triangulated | 12M | $16.52 | 12.4 | 1.33 | Triangulated | high |
| Peer P/E | 3Y | $7.58 | 12.4 | 0.61 | Analyst | medium |
| Peer P/S | 3Y | $40.68 | 2.9 | 14.13 | guidance | medium |
| Own P/E history | 3Y | $14.12 | 23.1 | 0.61 | Analyst | medium |
| Peer P/E | 5Y | $4.42 | 12.4 | 0.36 | Analyst | medium |
| Peer P/S | 5Y | $40.19 | 2.9 | 13.97 | guidance | medium |
| Own P/E history | 5Y | $8.24 | 23.1 | 0.36 | Analyst | medium |